BRPI0411623A - forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo - Google Patents

forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo

Info

Publication number
BRPI0411623A
BRPI0411623A BRPI0411623-2A BRPI0411623A BRPI0411623A BR PI0411623 A BRPI0411623 A BR PI0411623A BR PI0411623 A BRPI0411623 A BR PI0411623A BR PI0411623 A BRPI0411623 A BR PI0411623A
Authority
BR
Brazil
Prior art keywords
sporopolenin
spore
functionalized
exine
coating
Prior art date
Application number
BRPI0411623-2A
Other languages
English (en)
Inventor
Stephen Lawrence Atkin
Stephen Thomas Beckett
Grahame Mackenzie
Original Assignee
Univ Hull
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0315019A external-priority patent/GB0315019D0/en
Priority claimed from GB0411047A external-priority patent/GB0411047D0/en
Application filed by Univ Hull filed Critical Univ Hull
Publication of BRPI0411623A publication Critical patent/BRPI0411623A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"FORMA DE DOSAGEM FARMACêUTICA OU DIETéTICA, ESPOROPOLENINA, MéTODO PARA A FORMAçãO DE UMA ESPOROPOLENINA FUNCIONALIZADA COM AMINA PRIMARIA OU UM OUTRO REVESTIMENTO DE EXINA, MéTODO PARA A FORMAçãO DE UMA ESPOROPOLENINA FUNCIONALIZADA COM POLIAMINO OU UM OUTRO REVESTIMENTO DE EXINA DE UM ESPORO , MéTODO PARA A OBTENçãO DE UMA ESPOROPOLENINA FUNCIONALIZADA COM AMINOáCIDO OU UM OUTRO REVESTIMENTO DE EXINA DE UM ESPORO, ESPOROPOLENINA FUNCIONALIZADA OU UM OUTRO REVESTIMENTO DE EXINA DE UM ESPORO, FORMA DE DOSAGEM DIETéTICA OU FLAVORIZANTE, MéTODO DE PREENCHIMENTO DE REVESTIMENTOS DE EXINA DE ESPOROS, USO DA FORMA DE DOSAGEM E MéTODO DE APLICAçãO ORAL DE UM INGREDIENTE ATIVO". Trata-se de uma forma de dosagem farmacêutica ou dietética que compreende uma quantidade eficaz de uma substância ativa química ou fisicamente ligada a um suporte, que compreende esporopolenina, ou um outro revestimento de exina similar de esporos, de uma planta de fungo, opcionalmente com outros excipientes.
BRPI0411623-2A 2003-06-27 2004-06-28 forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo BRPI0411623A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0315019A GB0315019D0 (en) 2003-06-27 2003-06-27 Dosage form
GB0411047A GB0411047D0 (en) 2004-05-18 2004-05-18 Dosage form
PCT/GB2004/002775 WO2005000280A2 (en) 2003-06-27 2004-06-28 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin

Publications (1)

Publication Number Publication Date
BRPI0411623A true BRPI0411623A (pt) 2006-08-08

Family

ID=33554168

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411623-2A BRPI0411623A (pt) 2003-06-27 2004-06-28 forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo

Country Status (9)

Country Link
EP (1) EP1638538B1 (pt)
JP (1) JP5059402B2 (pt)
KR (1) KR101190766B1 (pt)
AU (1) AU2004251496B2 (pt)
BR (1) BRPI0411623A (pt)
CA (1) CA2530645C (pt)
MX (1) MXPA05013965A (pt)
MY (1) MY149933A (pt)
WO (1) WO2005000280A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608270B2 (en) 2003-06-27 2009-10-27 University Of Hull Dosage form
GB0427520D0 (en) * 2004-12-16 2005-01-19 Univ Hull Magnetic resonance contrast media
DE102005016714A1 (de) * 2005-04-11 2006-10-12 Maack, Andreas, Dipl.-Chem.Dr. Verwendung von Sporopollenin und/oder deren Derivaten als Bestandteil von Arzneimitteln, Medizinalprodukten und Nahrungsergänzungsmitteln
US8784851B2 (en) 2005-07-28 2014-07-22 University Of Hull Topical formulations containing sporopollenin
GB0724550D0 (en) * 2007-12-18 2008-01-30 Univ Hull Formulations
GB0812513D0 (en) 2008-07-09 2008-08-13 Univ Hull Delivery vehicle
GB2488838A (en) 2011-03-11 2012-09-12 Biomimetics Health Ind Ltd A stable antimicrobial aqueous hypochlorous acid solution
DE102012216190A1 (de) 2012-09-12 2014-04-10 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Komposite und Beschichtungsstoffe mit in biologischem Hüllmaterial inkludierten Wirkstoffen
EP3513805A1 (en) 2012-10-15 2019-07-24 Texas Tech University System Immunomodulation using spores and pollen grains
EP3528856B1 (en) 2016-10-18 2023-07-12 Marquette University Composite materials containing structural polymers and photoreactive nitric oxide releasing agents and uses thereof for wound dressings
US20200129575A1 (en) 2017-02-09 2020-04-30 Universidade De Santiago De Compostela Purified pollen particles and use thereof for administering nanosystems
US10913937B2 (en) 2017-04-17 2021-02-09 Lafayette College Degradation of sporopollenin
WO2019113396A1 (en) * 2017-12-08 2019-06-13 President And Fellows Of Harvard College Micro-and nanoneedles for plant and other cell penetration
US12239948B2 (en) 2019-06-17 2025-03-04 Marquette University Materials based on natural pollen grains and uses thereof
EP4297735A1 (en) 2021-02-26 2024-01-03 Sporomex Limited Methods for the extraction of dispersible microcapsules
GB202102748D0 (en) 2021-02-26 2021-04-14 Botanical Solutions Ltd Exine constructs
WO2022200762A1 (en) 2021-03-26 2022-09-29 Sporomex Limited Methods for the extraction of dispersible microcapsules (immunocontraception)
ES2994027B2 (es) 2023-07-11 2025-08-06 Univ Santiago Compostela Particulas de polen como vehiculos para administracion pulmonar

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116208A (ja) * 1982-12-24 1984-07-05 Kobayashi Kooc:Kk プレス状メイクアップ化粧料
JPS6359378A (ja) * 1986-08-28 1988-03-15 Kiteii:Kk 物体の表面に主剤を固着させる剤及び方法
US5013552A (en) * 1989-02-06 1991-05-07 Samir Amer Moh Modified pollen grains for delivering biologically active substances to plants and animals
JP2970957B2 (ja) * 1991-05-15 1999-11-02 株式会社グレイトチレン 精製花粉栄養調整物
CN1105594A (zh) * 1994-11-16 1995-07-26 潘自航 降癌灵丹
JP3368323B2 (ja) * 1997-05-14 2003-01-20 独立行政法人農業生物資源研究所 キチンビーズ、キトサンビーズ、これらビーズの製造方法及びこれらビーズからなる担体並びに微胞子虫胞子の製造法
DE19902724A1 (de) * 1999-01-19 2000-07-27 Dietmar Lerche Mikrokapseln aus Sporopollenin, Verfahren zu ihrer Herstellung und Anwendung

Also Published As

Publication number Publication date
MXPA05013965A (es) 2006-05-25
KR20060094848A (ko) 2006-08-30
EP1638538A2 (en) 2006-03-29
JP2007520430A (ja) 2007-07-26
WO2005000280A2 (en) 2005-01-06
KR101190766B1 (ko) 2012-10-12
MY149933A (en) 2013-10-31
AU2004251496A1 (en) 2005-01-06
EP1638538B1 (en) 2018-02-14
CA2530645C (en) 2013-05-07
AU2004251496B2 (en) 2009-10-01
WO2005000280A3 (en) 2005-06-16
CA2530645A1 (en) 2005-01-06
JP5059402B2 (ja) 2012-10-24

Similar Documents

Publication Publication Date Title
HRP20060240T3 (hr) Intranazalni pripravak rotigotina
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EA200300999A1 (ru) Хронотерапевтические дозированные формы
BRPI0412029A (pt) formulações para microprojeções revestidas contendo contra-ìons não-voláteis
BRPI0508125A (pt) formulação de alcalóide, método para melhorar a eficácia de um alcalóide, uso do produto da reação de um ou mais alcalóides com um mais derivados de fosfato de um ou mais agentes de transferência de elétrons, junto com excipientes e composição farmacêutica
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
ECSP024341A (es) Composiciones farmaceuticas
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
GB0323684D0 (en) Improvements in or relating to organic compounds
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
AR055319A1 (es) Derivados de isoquinoleina, composiciones farmaceuticas y usos
AU2357202A (en) Ion-strength independent sustained release pharmaceutical formulation
MA28862B1 (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
EA200600603A1 (ru) Оральная система доставки лекарственного препарата
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
WO2005000280A3 (en) Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
DE60311665D1 (de) Pharmazeutische zusammensetzungen
DK1250125T3 (da) Farmaceutiske præparater, som indeholder terbinafin
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
SE0202365D0 (sv) New formulation and use thereof
GB201006218D0 (en) Composition
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
BRPI0413750A (pt) uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/50 , A61K 9/20 , A61K 47/48 , A23L 1/00

Ipc: A61K 47/48 (2006.01), A61K 9/20 (2006.01), A61K 9/

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23P 10/30 (2016.01), A61K 9/20 (2006.01), A61K 9/